A double-peak phenomenon in the pharmacokinetics of acebutolol enantiomers after oral administration: Discontinuous absorption of acebutolol

Daru

Volumn 10, Issue 4, 2002, Pages 141-147

  Mostafavi, S Abolfazl ^a,b   Foster, Robert T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acebutolol; Double peaks; Enantiomer; Pharmacokinetics; Site dependent

Indexed keywords

ACEBUTOLOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BILE SECRETION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ENANTIOMER; MALE; NONHUMAN; PHARMACOKINETICS; RACEMIC MIXTURE; RAT;

EID: 0037949012     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gradman, A.H., Winkle, R.A., Fitsgerald, J.W., Meffin, P.J., Stoner, J., Bell, P.A., and Harrison, D.C. (1977) Suppression of premature ventricular contractions by acebutolol. Circulation. 55:785-91.
2. Biron, P., Tremblay, G. (1975) Differential antianginal responsiveness to acebutolol. Eur. J. Clin. Pharmacol. 8:15-19.
3. Piquette-Miller, M., Jamali, F. (1997) Pharmacokinetics and Multiple peaking of acebutolol enantiomers in the rat. Biopharm & Drug. Dispos. 18:543-556.
4. Mostafavi, S.A., Foster, R.T. (1998) Pharmacokinetics of single oral and multiple intravenous and oral administration of acebutolol enantiomers in a rat model. Biopharm & Drug. Dispos. 19: 425-431.
5. Mostafavi, S.A., Foster, R.T. (2002) Influence of cimetidine co-administration on the pharmacokientics of acebutolol enantiomers and its metabolite diacetolol in rat model: the effect of gastric pH on double peak phenomena. In. J. pharmaceutics (submitted for publication).
6. Meffin, P.J., Winkle, R.A., Peters, F.A., Harrison, D.C. (1978) Dose-dependent acebutolol disposition after oral administration. Clin. Pharmacol. Ther. 24:542-547.
7. Winkle, R.A., Meffin, P.J., Ricks, W.B., Harrison, D.C. (1977) Acebutolol metabolite plasma concentration during chronic oral therapy. Br. J. Clin. Pharmacol. 4:519-522.
8. Zaman, R., Wilkins, M.R., Kendall, M.J., Jack, D.B. (1984) The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite diacetolol. Biopharm & Drug. Dispos.5:91-95.
9. Piquette-Miller, M., Foster, R.T., Kappagoda, C.T., Jamali, F. (1991) Pharmacokinetics of acebutolol enantiomers in humans. J. Pharm. Sci. 80:313-316.
10. Roux, A., Guedon, J., Flouvat, B. (1980) Pharmacokinetics of acebutolol in patients with all grades of renal failure. Eur. J. Clin. Pharmacol. 17:339-348.
11. Piquette-Miller, M., Foster, R.T., Kappagoda, C.T. Jamali, F. (1992) Effect of aging on the pharmacokinetics of acebutolol enantiomers. J. Clin. Pharmacol.32:148-156.
12. Pederson, P.V., Miller, R. (1980) Pharmacokinetics and bioavailability of cimetidine in humans. J. Pharm.Sci.69:394-397.
13. Plusquellec, Y., Campistron, G., Staveris, S., Barre, J., Jung, L., Tillement, J.P., Houin, G. (1987) A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-side model for drug absorption. J. Pharmacokinet. Biopharm. 15:225-239.
14. Brockmeier, D., Grigoleit, H.G., Leonhardt, H. (1986) The absorption of piretanide from the gastro-intestinal tract is site-dependent. Eur. J. Clin. Pharmacol.30:79-82.
15. Suttle, A.B., Pollack, G.M., Brouwer. K.L.(1992) Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles. Pharm. Res. 9:350-356.
16. 14C-Polyethylene glycol 4000. Pharm. Res. 10:130-135.
17. Lennernas, H. and regardh, C.G. (1993) Evidence for an interaction between the β-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration-time profile. Pharm. Res. 10:879-883.
18. Clements, J.A., Heading, R.C., Nmmo, W.S., and Prescott, L.F. (1978) Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol & Ther. 24:1420-31.
19. Keneniwa, N., Funki, T., Furuta, S., Watari, N. (1986) Study of absorption site of cimetidine. J. Pharmcobio-Dynamics. 9:321-6.
20. Mummaneni, V., Amidon, G.L., Dressman. J.B. (1995) Gastric pH influences the appearance of double peaks in the plasma concentration-time profile of cimetidine after oral administration in dogs. Pharm. Res. 12:780-786.
21. Grahnen, A., Von Bahr, C., Lindstrom, B., and Rosen, A.(1979) Bioavailability and pharmacokinetics of cimetidine. Eur. j. Clin. Pharmacol. 16:335-340.
22. Mostafavi, S.A., Foster, R.T. (1997) Pharmacokinetics of acebutolol enantiomers after iv administration of racemate in a rat model: a dosing range comparison. Biopharm Drug Dispos. 18:397-408.
23. Piquette-Miller, M., Foster, R.T., Pasutto, F.M., and Jamali, F. (1990) Stereoselective high-performance liquid chromatographic assay of acebutolol in human plasma and urine. J. Chromatogr. 529:129-137.
24. Piquette-Miller, M., Foster. R.T.(1990) High-performance liquid chromatographic determination of diacetolol. J Chromatogr. 533:300-303.
25. Plusquellec, Y., Huin. G. (1994) Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract. Arzneim Forsch. Drug. Res. 44:679-682.